Skip to content

Bristol-Myers Squibb BMY Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin70.5%0.0pp71.1%0.0pp69.5%-5.4pp70.3%-5.1pp70.5%-5.2pp
Net margin15%+3.8pp14.6%+33.3pp12.4%+27.7pp10.4%+24.5pp11.2%+24.7pp
Returns
Return on equity38.8%+7.3pp40.5%+79.9pp33.4%+64.9pp28.9%+55.6pp31.6%+57.0pp
Return on invested capital13%+4.2pp12.5%+27.2pp10.6%+22.0pp8.3%+18.5pp8.8%+18.1pp
Efficiency
Asset turnover0.5×0.0×0.5×0.0×0.5×0.0×0.5×0.0×0.5×0.0×
Liquidity
Current ratio1.4×+0.1×1.3×0.0×1.3×0.0×1.2×+0.1×1.3×+0.2×
Leverage
Debt-to-equity2.2×-0.6×2.6×-0.6×2.7×-0.3×2.8×-0.3×2.9×-0.5×
Net debt / EBITDA2.7×-0.1×2.8×-36.3×2.6×-10.1×2.8×-10.0×2.8×-8.8×
Valuation
Market capitalization$123.83B-0.2%$109.81B-4.3%$91.8B-12.5%$95.71B+13.7%$124.1B+13.2%
Price / earnings17×-6.2×15.6×15.4×19.2×23.2×
Price / sales2.6×-0.1×2.3×-0.1×1.9×-0.3×+0.2×2.6×+0.2×
Price / book6.2×-1.0×5.9×-1.1×4.9×-1.2×5.5×+0.5×7.1×+0.5×
EV / EBITDA12×+0.4×11×-138×9.8×-34.7×10.3×-25.9×11.6×-27.2×
Dividend yield4.1%+0.1pp4.6%+0.4pp5.4%+0.9pp5.2%-0.5pp4%-0.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Bristol-Myers Squibb's ratios come from?
Every ratio is computed from Bristol-Myers Squibb's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.